• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

壳聚糖纳米颗粒的生物安全性与生物分布

Biological Safety and Biodistribution of Chitosan Nanoparticles.

作者信息

Sonin Dmitry, Pochkaeva Evgeniia, Zhuravskii Sergei, Postnov Viktor, Korolev Dmitry, Vasina Lyubov, Kostina Daria, Mukhametdinova Daria, Zelinskaya Irina, Skorik Yury, Naumysheva Elena, Malashicheva Anna, Somov Pavel, Istomina Maria, Rubanova Natalia, Aleksandrov Ilia, Vasyutina Marina, Galagudza Michael

机构信息

Almazov National Medical Research Centre, Institute of Experimental Medicine, 2 Akkuratova str., 197341 Saint Petersburg, Russia.

Pavlov First Saint Petersburg State Medical University, Laboratory of Biophysics of Blood Circulation, 6-8 L'va Tolstogo str., 197022 Saint Petersburg, Russia.

出版信息

Nanomaterials (Basel). 2020 Apr 23;10(4):810. doi: 10.3390/nano10040810.

DOI:10.3390/nano10040810
PMID:32340313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7221586/
Abstract

The effect of unmodified chitosan nanoparticles with a size of ~100 nm and a weakly positive charge on blood coagulation, metabolic activity of cultured cardiomyocytes, general toxicity, biodistribution, and reactive changes in rat organs in response to their single intravenous administration at doses of 1, 2, and 4 mg/kg was studied. Chitosan nanoparticles (CNPs) have a small cytotoxic effect and have a weak antiplatelet and anticoagulant effect. Intravenous administration of CNPs does not cause significant hemodynamic changes, and 30 min after the CNPs administration, they mainly accumulate in the liver and lungs, without causing hemolysis and leukocytosis. The toxicity of chitosan nanoparticles was manifested in a dose-dependent short-term delay in weight gain with subsequent recovery, while in the 2-week observation period no signs of pain and distress were observed in rats. Granulomas found in the lungs and liver indicate slow biodegradation of chitosan nanoparticles. In general, the obtained results indicate a good tolerance of intravenous administration of an unmodified chitosan suspension in the studied dose range.

摘要

研究了粒径约100 nm且带弱正电荷的未修饰壳聚糖纳米颗粒,以1、2和4 mg/kg的剂量单次静脉注射对大鼠血液凝固、培养心肌细胞的代谢活性、一般毒性、生物分布以及大鼠器官反应性变化的影响。壳聚糖纳米颗粒(CNPs)具有较小的细胞毒性作用,且具有较弱的抗血小板和抗凝作用。静脉注射CNPs不会引起显著的血流动力学变化,在注射CNPs后30分钟,它们主要积聚在肝脏和肺中,不会引起溶血和白细胞增多。壳聚糖纳米颗粒的毒性表现为剂量依赖性的体重增加短期延迟,随后恢复,而在2周的观察期内,未观察到大鼠有疼痛和痛苦的迹象。在肺和肝脏中发现的肉芽肿表明壳聚糖纳米颗粒的生物降解缓慢。总体而言,所得结果表明在研究的剂量范围内,静脉注射未修饰的壳聚糖悬浮液具有良好的耐受性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/666b/7221586/ab416331e69c/nanomaterials-10-00810-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/666b/7221586/09e9b1789402/nanomaterials-10-00810-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/666b/7221586/ab416331e69c/nanomaterials-10-00810-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/666b/7221586/09e9b1789402/nanomaterials-10-00810-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/666b/7221586/ab416331e69c/nanomaterials-10-00810-g004.jpg

相似文献

1
Biological Safety and Biodistribution of Chitosan Nanoparticles.壳聚糖纳米颗粒的生物安全性与生物分布
Nanomaterials (Basel). 2020 Apr 23;10(4):810. doi: 10.3390/nano10040810.
2
In vivo toxicity evaluation of tumor targeted glycol chitosan nanoparticles in healthy mice: repeated high-dose of glycol chitosan nanoparticles potentially induce cardiotoxicity.在健康小鼠体内的肿瘤靶向性壳聚糖纳米粒的毒性评价:重复给予高剂量的壳聚糖纳米粒可能会导致心脏毒性。
J Nanobiotechnology. 2023 Mar 9;21(1):82. doi: 10.1186/s12951-023-01824-3.
3
Fabrication and characterization of chitosan conjugated eurycomanone nanoparticles: In vivo evaluation of the biodistribution and toxicity in fish.壳聚糖接枝拉坦前列素纳米粒的制备及表征:体内分布和鱼毒性评价。
Int J Biol Macromol. 2018 Jun;112:1093-1103. doi: 10.1016/j.ijbiomac.2018.02.067. Epub 2018 Feb 13.
4
Cytotoxicity and Genotoxicity in Human Embryonic Kidney Cells Exposed to Surface Modify Chitosan Nanoparticles Loaded with Curcumin.暴露于负载姜黄素的表面修饰壳聚糖纳米颗粒的人胚肾细胞中的细胞毒性和基因毒性。
AAPS PharmSciTech. 2016 Dec;17(6):1347-1352. doi: 10.1208/s12249-015-0471-1. Epub 2015 Dec 30.
5
Facile method to radiolabel glycol chitosan nanoparticles with (64)Cu via copper-free click chemistry for MicroPET imaging.通过无铜点击化学将(64)Cu 放射性标记到乙二醇壳聚糖纳米颗粒上的简便方法,用于 MicroPET 成像。
Mol Pharm. 2013 Jun 3;10(6):2190-8. doi: 10.1021/mp300601r. Epub 2013 May 6.
6
T1-Weighted MR imaging of liver tumor by gadolinium-encapsulated glycol chitosan nanoparticles without non-specific toxicity in normal tissues.载钆壳聚糖纳米粒的 T1 加权 MR 成像在正常组织中无非特异性毒性的肝脏肿瘤
Nanoscale. 2016 May 5;8(18):9736-45. doi: 10.1039/c5nr06673e.
7
Chitosan nanoparticles from Artemia salina inhibit progression of hepatocellular carcinoma in vitro and in vivo.卤虫来源壳聚糖纳米粒在体内外抑制肝癌进展。
Environ Sci Pollut Res Int. 2020 Jun;27(16):19016-19028. doi: 10.1007/s11356-018-3339-6. Epub 2018 Oct 6.
8
Chitosan nanoparticles: A positive immune response modulator as display in zebrafish larvae against Aeromonas hydrophila infection.壳聚糖纳米颗粒:作为展示在斑马鱼幼虫对嗜水气单胞菌感染的正向免疫反应调节剂。
Fish Shellfish Immunol. 2018 May;76:240-246. doi: 10.1016/j.fsi.2018.03.010. Epub 2018 Mar 3.
9
Eudragit S100-Coated Chitosan Nanoparticles Co-loading Tat for Enhanced Oral Colon Absorption of Insulin.载有Tat的Eudragit S100包衣壳聚糖纳米粒用于增强胰岛素的口服结肠吸收
AAPS PharmSciTech. 2017 May;18(4):1277-1287. doi: 10.1208/s12249-016-0594-z. Epub 2016 Aug 1.
10
Inhalable chitosan nanoparticles as antitubercular drug carriers for an effective treatment of tuberculosis.可吸入壳聚糖纳米颗粒作为抗结核药物载体,有效治疗结核病。
Artif Cells Nanomed Biotechnol. 2016 May;44(3):997-1001. doi: 10.3109/21691401.2015.1008508. Epub 2015 Feb 14.

引用本文的文献

1
Chitosan Nanoparticles Enhance the Antiproliferative Effect of Lapachol in Urothelial Carcinoma Cell Lines.壳聚糖纳米颗粒增强拉帕醇对膀胱癌细胞系的抗增殖作用。
Pharmaceutics. 2025 Jul 2;17(7):868. doi: 10.3390/pharmaceutics17070868.
2
Unlocking ginsenosides' therapeutic power with polymer-based delivery systems: current applications and future perspectives.利用基于聚合物的递送系统释放人参皂苷的治疗潜力:当前应用与未来展望。
Front Pharmacol. 2025 Jul 10;16:1629803. doi: 10.3389/fphar.2025.1629803. eCollection 2025.
3
Impacts of -loaded chitosan nanoparticles against indomethacin induced peptic ulcer in rats: promising therapy with enhanced bioavailability and gastro-protective activity.

本文引用的文献

1
Polysaccharides in Ocular Drug Delivery.眼部给药中的多糖
Pharmaceutics. 2019 Dec 24;12(1):22. doi: 10.3390/pharmaceutics12010022.
2
Pharmaceutical applications of chitosan.壳聚糖的药物应用。
Adv Colloid Interface Sci. 2019 Jan;263:131-194. doi: 10.1016/j.cis.2018.11.008. Epub 2018 Nov 30.
3
Biocompatibility studies of intravenously administered ionic-crosslinked chitosan-BSA nanoparticles as vehicles for antitumour drugs.静脉注射离子交联壳聚糖-BSA 纳米粒作为抗肿瘤药物载体的生物相容性研究。
负载的壳聚糖纳米颗粒对吲哚美辛诱导的大鼠消化性溃疡的影响:具有增强生物利用度和胃保护活性的有前景的治疗方法。
Toxicol Res (Camb). 2025 May 15;14(3):tfaf034. doi: 10.1093/toxres/tfaf034. eCollection 2025 Jun.
4
Chitosan Nanoparticles: Approaches to Preparation, Key Properties, Drug Delivery Systems, and Developments in Therapeutic Efficacy.壳聚糖纳米颗粒:制备方法、关键特性、药物递送系统及治疗效果的进展
AAPS PharmSciTech. 2025 Apr 17;26(5):108. doi: 10.1208/s12249-025-03100-z.
5
Chitosan as a Plurivalent Biopolymer in Nanodelivery Systems.壳聚糖作为纳米递送系统中的多价生物聚合物
Polymers (Basel). 2025 Feb 20;17(5):558. doi: 10.3390/polym17050558.
6
Nanoparticle Formulations for Intracellular Delivery in Colorectal Cancer Therapy.用于结直肠癌治疗中细胞内递送的纳米颗粒制剂
AAPS PharmSciTech. 2025 Mar 7;26(3):81. doi: 10.1208/s12249-025-03069-9.
7
Development, Characterization, and Evaluation of Chi-Tn mAb-Functionalized DOTAP-PLGA Hybrid Nanoparticles Loaded with Docetaxel for Lung Cancer Therapy.用于肺癌治疗的负载多西他赛的壳聚糖-转铁蛋白单克隆抗体功能化DOTAP-PLGA杂化纳米颗粒的研发、表征及评价
Pharmaceutics. 2025 Jan 25;17(2):164. doi: 10.3390/pharmaceutics17020164.
8
Optimization, physicochemical stability and in vivo study of alginate-chitosan composites as nanocarriers for low molecular weight angiotensin I-converting enzyme (ACE)-inhibitory peptide.藻酸盐-壳聚糖复合材料作为低分子量血管紧张素转换酶(ACE)抑制肽纳米载体的优化、理化稳定性及体内研究
J Food Drug Anal. 2024 Sep 13;32(3):358-370. doi: 10.38212/2224-6614.3522.
9
Precision Nanomedicine: Lapatinib-Loaded Chitosan-Gold Nanoparticles Targeting LINC01615 for Lung Cancer Therapy.精准纳米医学:载拉帕替尼壳聚糖-金纳米粒靶向 LINC01615 用于肺癌治疗。
AAPS J. 2024 Nov 19;27(1):4. doi: 10.1208/s12248-024-00990-y.
10
CpG oligodeoxynucleotide-coated chitosan nanoparticles enhance macrophage proinflammatory phenotype in vitro.CpG 寡脱氧核苷酸包被的壳聚糖纳米颗粒在体外增强巨噬细胞促炎表型。
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae081.
Int J Pharm. 2019 Jan 10;554:337-351. doi: 10.1016/j.ijpharm.2018.11.027. Epub 2018 Nov 12.
4
Chitosan-Based Composite Materials for Prospective Hemostatic Applications.壳聚糖基复合材料在潜在止血应用中的研究进展。
Mar Drugs. 2018 Aug 4;16(8):273. doi: 10.3390/md16080273.
5
Controlled formation of chitosan particles by a clock reaction.通过钟反应控制壳聚糖颗粒的形成。
Soft Matter. 2018 Aug 21;14(31):6415-6418. doi: 10.1039/c8sm01060a. Epub 2018 Jul 31.
6
Chitosan as a bioactive polymer: Processing, properties and applications.壳聚糖作为一种生物活性聚合物:加工、性能与应用。
Int J Biol Macromol. 2017 Dec;105(Pt 2):1358-1368. doi: 10.1016/j.ijbiomac.2017.07.087. Epub 2017 Jul 20.
7
Synthesis of N-succinyl- and N-glutaryl-chitosan derivatives and their antioxidant, antiplatelet, and anticoagulant activity.N-琥珀酰壳聚糖和 N-戊二酰壳聚糖衍生物的合成及其抗氧化、抗血小板和抗凝血活性。
Carbohydr Polym. 2017 Jun 15;166:166-172. doi: 10.1016/j.carbpol.2017.02.097. Epub 2017 Feb 27.
8
Role of Physicochemical Properties in Nanoparticle Toxicity.物理化学性质在纳米颗粒毒性中的作用。
Nanomaterials (Basel). 2015 Aug 19;5(3):1351-1365. doi: 10.3390/nano5031351.
9
Safety and toxicology of the intravenous administration of Ang2‑siRNA plasmid chitosan magnetic nanoparticles.血管生成素2-小干扰RNA质粒壳聚糖磁性纳米粒静脉注射的安全性与毒理学
Mol Med Rep. 2017 Feb;15(2):736-742. doi: 10.3892/mmr.2016.6090. Epub 2016 Dec 29.
10
Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency.壳聚糖修饰的聚(d,l-乳酸-共-乙醇酸)纳米粒在血流中的短暂聚集及提高的肺靶向效率。
J Colloid Interface Sci. 2016 Oct 15;480:102-108. doi: 10.1016/j.jcis.2016.07.006. Epub 2016 Jul 6.